Table 48.1.
Cancerous |
Normal |
||||||
---|---|---|---|---|---|---|---|
Patient | Redox ratiot | NADHt (μM) | Fpt | Redox ration | NADHn (μM) | Fpn (μM) | Fpt/Fpn |
1a | 0.71 | 153 | 569 | 0.42 | 86 | 65 | 9.2 |
2b | 0.52 | 699 | 759 | 0.31 | 153 | 69 | 11.1 |
3c | 0.59 | 295 | 601 | 0.48 | 174 | 221 | 2.7 |
Mean | 0.61 | 384 | 652 | 0.40 | 138 | 118 | 7.7d |
SD | 0.10 | 281 | 93 | 0.09 | 46 | 89 | 4.4 |
p valuee | 0.062 | 0.248 | 0.027 |
2.1 cm, invasive ductal carcinoma (IDC), triple negative (TN) receptors, negative nodes, poorly differentiated, 3 core biopsies, and 1 normal tissue block
3 cm, BRCA1 mutation, TN, negative nodes, poorly differentiated, 1 core biopsy, and 1 normal tissue block
10 cm, ER+, positive node, Arimidex treated for 6 months, 1 cancer and 1 normal tissue block
Average of Fpt/Fpn over the three patients
Comparison of the redox indices between cancerous and normal tissue of the three patients